These Are The Five Best And Worst Performing Large-Cap Stocks In September 202224/7 Wall Street • 10/10/22
Investors of Biogen Stock Since At Least January 2022 Encouraged to Contact Kehoe Law Firm, P.C. - Breach of Fiduciary Duties Investigation - BIIBNewsfile Corp • 10/07/22
Biogen and Alzheimer's drug development companies surge on positive clinical dataProactive Investors • 09/30/22
Biogen Announced EMA Filing Acceptance of BIIB800, A Biosimilar Candidate Referencing RoACTEMRA® (tocilizumab)GlobeNewsWire • 09/30/22
New Alzheimer's drug slows disease in major clinical trial: ‘Blockbuster potential'New York Post • 09/28/22